Search results
A timeline of 'Perfect Match' contestant Harry Jowsey's relationship history
Business Insider· 2 days agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
Northwich Victoria bosses reveal sights are set high for the new season
Northwich & Winsford Guardian via Yahoo News UK· 3 days ago“Last year when I came in I remember the first training session I attended and we had to cut it...
King Charles' gardener's reveals urgent job for July to keep flowers growing
The Sun· 1 day agoNow is also a good time to be staking plants, any tall flower heads that you don’t want to lose you...
Dog Rescued After Being Abandoned and Tied to a Pole with a Note Alongside Highway: ‘See That She...
People via Yahoo News UK· 2 days ago"[The highway] is no place to abandon a 4-year-old animal, and leaving a note with well-wishes just...
I'm a sushi chef and these are the rules to follow when eating it
Daily Mail· 13 hours agoTop sushi chefs have revealed their must-follow rules for any diners enjoying the Japanese delicacy....
Radioactive pellets are newest weapon in battle to save rhinos
Daily Telegraph· 6 hours agoRadioactive pellets have been implanted into the horns of rhinoceroses in South Africa as part of a...
Strong Q2 orders boost Aixtron shares despite lowered outlook
Reuters· 1 day agoShares in Aixtron soared 16% on Friday after a strong second-quarter order intake soothed concerns...
Here’s which Walkers crisp you are according to your star sign
Metro· 11 hours agoKerry says: ‘Capricorns have a dry humour, a sarcastic attitude, and a sharp tongue. They don’t...
Dave Grohl Is Nearly Unrecognizable in Polished Suit and Slicked Back Ponytail in Royal Box at...
People via Yahoo News UK· 4 days agoSo the Grammy-winning musician's usual wardrobe wasn't going to cut it for the day! According to the...
Citi cuts GSK target price after Arexy disappointment, but stays at 'buy'
ShareCast· 1 day agoCiti has reiterated its 'buy' rating on GSK despite a flurry of disappointing news for the biopharma...